Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphorylase kinase regulatory subunit beta pseudogene 1 (PHKBP1) is annotated as a **pseudogene**, which means it is a genomic DNA sequence similar to the functional **phosphorylase kinase beta subunit gene (PHKB)** but does not encode a functional protein[1][8]. Pseudogenes can sometimes regulate their parent genes through non-coding RNA mechanisms, such as serving as microRNA decoys or affecting mRNA stability[2][5]; however, there is no evidence that PHKBP1 itself exerts such effects. It has no direct role in disease as a target, and is not referenced as a drug target, disease biomarker, or molecular receptor/enzyme/transporter. The parent gene, **PHKB**, encodes the beta subunit of phosphorylase b kinase, which plays an important role in glycogen metabolism[7], but PHKBP1, as a pseudogene, does not encode this protein. In summary, PHKBP1 is a non-coding pseudogene with annotation only in genomic databases and is not considered a therapeutic target[1][8].
None (not a pharmacological target; thus, no mechanisms of drug action)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphorylase kinase regulatory subunit beta pseudogene 1 (PHKBP1).